• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 末端脑利钠肽前体(NT-proBNP)联合 D-二聚体对急性冠状动脉综合征患者经皮冠状动脉介入治疗后无复流现象的预测价值。

Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention.

机构信息

Department of Emergency, Yidu Central Hospital of Weifang, Weifang, Shandong, China.

Clinical Internal Medicine, Qingzhou Mihe Central Health Center, Shandong, Weifang, China.

出版信息

Bioengineered. 2021 Dec;12(1):8614-8621. doi: 10.1080/21655979.2021.1988361.

DOI:10.1080/21655979.2021.1988361
PMID:34612772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8806976/
Abstract

Acute coronary syndrome (ACS) is a critical illness in cardiovascular disease. The purpose of this study was to investigate the value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and D-dimer in predicting the occurrence of no reflow in emergency percutaneous coronary intervention (PCI) in patients with ACS. One hundred and sixty-eight ACS patients were recruited, including 88 patients with normal reflow and 80 patients with no reflow after emergency PCI. The levels of serum NT-proBNP and D-dimer in the patients were detected before PCI, immediately after PCI, 2 hours, and 6 months after PCI. The ROC curve was used to evaluate the predictive value of NT-proBNP and D-dimer in no-reflow phenomenon. Logistic regression model was used to analyze the independent influencing factors of no reflow phenomenon. Logistic regression analysis confirmed that NT-proBNP and D-dimer were independent predictors of the occurrence of no reflow in the total population. The ROC curve showed that the AUC value was 0.909 when NT-proBNP combined with D-dimer. The detection of NT-proBNP combined with D-dimer was helpful to predict the occurrence of no-reflow phenomenon after emergency PCI in ACS patients.

摘要

急性冠状动脉综合征(ACS)是心血管疾病中的一种危急病症。本研究旨在探讨 N 末端脑钠肽前体(NT-proBNP)和 D-二聚体在预测 ACS 患者急诊经皮冠状动脉介入治疗(PCI)中无复流发生的价值。纳入 168 例 ACS 患者,其中 88 例为再灌注正常,80 例为急诊 PCI 后无复流。检测患者 PCI 前、PCI 后即刻、2 小时和 6 个月时的血清 NT-proBNP 和 D-二聚体水平。采用 ROC 曲线评估 NT-proBNP 和 D-二聚体对无复流现象的预测价值。采用 logistic 回归模型分析无复流现象的独立影响因素。Logistic 回归分析证实,NT-proBNP 和 D-二聚体是总人群无复流发生的独立预测因素。ROC 曲线显示,当 NT-proBNP 联合 D-二聚体检测时,AUC 值为 0.909。检测 NT-proBNP 联合 D-二聚体有助于预测 ACS 患者急诊 PCI 后无复流现象的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d257/8806976/3350de146987/KBIE_A_1988361_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d257/8806976/7374e02fb692/KBIE_A_1988361_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d257/8806976/3350de146987/KBIE_A_1988361_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d257/8806976/7374e02fb692/KBIE_A_1988361_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d257/8806976/3350de146987/KBIE_A_1988361_F0002_B.jpg

相似文献

1
Predictive value of N-terminal pro-B-type natriuretic peptide (NT-pro BNP) combined with D-dimer for no-reflow phenomenon in patients with acute coronary syndrome after emergency of percutaneous coronary intervention.N 末端脑利钠肽前体(NT-proBNP)联合 D-二聚体对急性冠状动脉综合征患者经皮冠状动脉介入治疗后无复流现象的预测价值。
Bioengineered. 2021 Dec;12(1):8614-8621. doi: 10.1080/21655979.2021.1988361.
2
The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.NT-proBNP 对行直接经皮冠状动脉介入治疗患者早期风险分层入院的影响。
Kardiol Pol. 2013;71(2):165-75. doi: 10.5603/KP.2013.0011.
3
[Prognostic significance of admission N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction].[急性心肌梗死患者经皮冠状动脉介入治疗时入院N末端脑钠肽前体对预测血管造影无复流现象的预后意义]
Zhonghua Yi Xue Za Zhi. 2012 Dec 25;92(48):3403-6.
4
The association of baseline N-terminal pro-B-type natriuretic peptide with short and long-term prognosis following percutaneous coronary intervention in non-ST segment elevation acute coronary syndrome with multivessel coronary artery disease: a retrospective cohort study.基线 N 末端脑利钠肽前体与多支冠状动脉病变非 ST 段抬高型急性冠状动脉综合征经皮冠状动脉介入治疗后短期和长期预后的相关性:一项回顾性队列研究。
BMC Cardiovasc Disord. 2021 Apr 21;21(1):202. doi: 10.1186/s12872-021-02010-9.
5
The Value of Combining Plasma D-Dimer and Endothelin-1 Levels to Predict No-Reflow After Percutaneous Coronary Intervention of ST-Segment Elevation in Acute Myocardial Infarction Patients with a Type 2 Diabetes Mellitus History.联合检测血浆 D-二聚体和内皮素-1 水平对伴有 2 型糖尿病史的急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后无复流的预测价值。
Med Sci Monit. 2018 May 28;24:3549-3556. doi: 10.12659/MSM.908980.
6
Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.术前N端前脑钠肽在预测ST段抬高型急性心肌梗死患者支架植入术中血管造影无复流现象的价值
Am J Cardiol. 2007 Aug 15;100(4):631-4. doi: 10.1016/j.amjcard.2007.03.075. Epub 2007 Jun 28.
7
Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome.急性冠状动脉综合征患者经皮冠状动脉介入治疗中N末端前脑钠肽水平与造影剂肾病的相关性
Clin Cardiol. 2014 Aug;37(8):485-92. doi: 10.1002/clc.22291. Epub 2014 May 7.
8
Relationship of Red Cell Volume Distribution Width and N-Terminal Pro-Brain Natriuretic Peptide with Severity and Prognosis of Patients with Acute Coronary Syndrome Receiving Percutaneous Coronary Intervention.红细胞体积分布宽度和 N 末端脑利钠肽前体与接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者严重程度及预后的关系。
Clin Lab. 2020 Apr 1;66(4). doi: 10.7754/Clin.Lab.2019.190513.
9
A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.非ST段抬高型急性冠状动脉综合征的多标志物风险分层方法:肌钙蛋白T、CRP、NT-proBNP和纤维蛋白D-二聚体水平的意义
J Intern Med. 2007 Dec;262(6):651-8. doi: 10.1111/j.1365-2796.2007.01871.x. Epub 2007 Nov 7.
10
Pre-Procedural N-Terminal Pro-B Type Natriuretic Peptide Predicts Contrast-Induced Acute Kidney Injury and Long-Term Outcome in Elderly Patients After Elective Percutaneous Coronary Intervention.术前N端B型利钠肽原可预测老年患者择期经皮冠状动脉介入治疗后对比剂诱导的急性肾损伤及长期预后。
Int Heart J. 2018 Sep 26;59(5):926-934. doi: 10.1536/ihj.17-573. Epub 2018 Aug 29.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
Association between NT-proBNP level and the number of stents with major advanced cardiovascular events (MACE) in patients with multivessel coronary artery disease treated with percutaneous coronary intervention: A prospective cohort study.经皮冠状动脉介入治疗多支冠状动脉疾病患者 NT-proBNP 水平与支架数量及主要心血管不良事件(MACE)的关系:一项前瞻性队列研究。
Narra J. 2024 Apr;4(1):e710. doi: 10.52225/narra.v4i1.710. Epub 2024 Apr 16.
3

本文引用的文献

1
Can the development of atrial fibrillation in patients with ischemic heart failure with low ejection fraction be predicted?射血分数低的缺血性心力衰竭患者发生心房颤动的情况能否被预测?
North Clin Istanb. 2019 Oct 8;7(1):18-24. doi: 10.14744/nci.2019.07078. eCollection 2020.
2
D-dimer level predicts in-hospital adverse outcomes after primary PCI for ST-segment elevation myocardial infarction.D-二聚体水平可预测ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后的院内不良结局。
Int J Cardiol. 2020 Apr 15;305:1-4. doi: 10.1016/j.ijcard.2020.02.010. Epub 2020 Feb 4.
3
The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis.
The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction.
经皮冠状动脉介入治疗对慢性完全性冠状动脉阻塞患者生物标志物及生活质量的影响
Cardiol Res. 2023 Feb;14(1):69-78. doi: 10.14740/cr1455. Epub 2023 Feb 25.
4
Identification of key molecular markers of acute coronary syndrome using peripheral blood transcriptome sequencing analysis and mRNA-lncRNA co-expression network construction.利用外周血转录组测序分析和 mRNA-lncRNA 共表达网络构建鉴定急性冠状动脉综合征的关键分子标志物。
Bioengineered. 2021 Dec;12(2):12087-12106. doi: 10.1080/21655979.2021.2003932.
ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后无复流现象的预测因素:一项荟萃分析。
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S406-S418. doi: 10.1016/j.ihj.2018.01.032. Epub 2018 Jan 31.
4
Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction.经冠状动脉间质干细胞治疗前壁 ST 段抬高型心肌梗死患者左心室功能改善。
Cardiovasc Drugs Ther. 2018 Aug;32(4):329-338. doi: 10.1007/s10557-018-6804-z.
5
The Value of Combining Plasma D-Dimer and Endothelin-1 Levels to Predict No-Reflow After Percutaneous Coronary Intervention of ST-Segment Elevation in Acute Myocardial Infarction Patients with a Type 2 Diabetes Mellitus History.联合检测血浆 D-二聚体和内皮素-1 水平对伴有 2 型糖尿病史的急性 ST 段抬高型心肌梗死患者经皮冠状动脉介入治疗后无复流的预测价值。
Med Sci Monit. 2018 May 28;24:3549-3556. doi: 10.12659/MSM.908980.
6
Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club.经皮冠状动脉介入治疗左主干和其他分叉病变:来自欧洲分叉俱乐部的第 12 次共识文件。
EuroIntervention. 2018 Jan 20;13(13):1540-1553. doi: 10.4244/EIJ-D-17-00622.
7
Risk Factors for No-Reflow Phenomenon after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.急性冠状动脉综合征患者经皮冠状动脉介入治疗后无复流现象的危险因素
Rev Invest Clin. 2017 May-Jun;69(3):139-145. doi: 10.24875/ric.17002190.
8
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study.急性冠脉综合征后转换双联抗血小板治疗的获益:TOPIC(急性冠脉综合征后血小板抑制的时机)随机研究。
Eur Heart J. 2017 Nov 1;38(41):3070-3078. doi: 10.1093/eurheartj/ehx175.
9
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.ST段抬高型心肌梗死经皮冠状动脉介入治疗中的无复流现象
Indian Heart J. 2016 Jul-Aug;68(4):539-51. doi: 10.1016/j.ihj.2016.04.006. Epub 2016 Apr 19.
10
Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.血小板/淋巴细胞比值与接受直接冠状动脉介入治疗的ST段抬高型急性心肌梗死患者的心肌灌注受损以及院内和长期不良结局相关。
Postepy Kardiol Interwencyjnej. 2015;11(4):288-97. doi: 10.5114/pwki.2015.55599. Epub 2015 Jan 12.